Max McGrath

Max McGrath

Auto-generated profile, based on publicly available information

Max McGrath

University of Colorado Anschutz Medical Campus

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
PDPeter J. Dunbar
Peter J. Dunbar
RPRyan Peterson
Ryan Peterson
MMMax McGrath
Max McGrath
TKTyree H. Kiser
Tyree H. Kiser
PHP. Michael Ho
P. Michael Ho
PSPeter D. Sottile
Peter D. Sottile
Rationale: Neuromuscular blockade (NMB) is frequently used during acute respiratory distress syndrome (ARDS) to improve ventilator synchrony. Which sedating medications are used concomitantly during NMB and whether sedation choice influences patient outcomes are unclear. Objectives: To determine national sedation practice patterns during NMB in patients with and at risk for ARDS and to establish whether the use of propofol and opioids compared with benzodiazepines and opioids is associated with improved outcomes. Methods: Using a U.S. national database from 2010 to 2021, intubated and mechanically ventilated patients receiving NMB for a diagnosis of ARDS or an ARDS risk factor over at least two hospital days after admission were included. Charges for sedation and analgesia during the first two hospital days were recorded for each patient. The relationships between propofol and opioids and between benzodiazepines and opioids, with a primary outcome of ventilator-free days, as well as secondary outcomes of 28-day survival and discharge home were examined in multivariable analyses. Results: We determined that the use of propofol has increased compared with that of benzodiazepines as the primary sedative used during NMB for ARDS. Compared with benzodiazepine and opioid use, propofol and opioid use during NMB for ARDS was associated with increased ventilator-free days (adjusted odds ratio, 1.38 [95% confidence interval, 1.24–1.54]), greater odds for survival at 28 days (adjusted odds ratio, 1.15 [95% confidence interval, 1.01–1.31]), and greater odds for discharge home (adjusted odds ratio, 1.26 [95% confidence interval, 1.09–1.46]), adjusting for patient-level and hospital-level characteristics. Conclusions: From 2010 to 2021, sedation practice during NMB for ARDS shifted from predominately benzodiazepine use to predominately propofol use. The use of propofol and opioids is associated with an increase in ventilator-free days compared with the use of benzodiazepines and opioids. These results suggest that sedation choice during NMB for ARDS may affect clinical outcomes; further investigation is needed to validate these findings.

3 September 2025 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
KHKelsey Hills-Dunlap
Kelsey Hills-Dunlap
MMMax McGrath
Max McGrath
RPRyan Peterson
Ryan Peterson
ACAriyani Challapalli
Ariyani Challapalli
PHP. Michael Ho
P. Michael Ho
EBEllen L. Burnham
Ellen L. Burnham
Background: Substance use is an important contributor to morbidity, mortality, and healthcare utilization in the United States. While prior research has explored regional differences in substance use and related hospitalizations, the geographic variation in substance-related ICU admissions remains underexplored. We sought to compare the prevalence of ICU admissions involving substance use across geographic divisions and between urban and rural ICUs in the United States. Methods: Using the national PINC AI Healthcare Database, we performed a retrospective observational study of adult ICU admissions between January 1, 2016 and December 31, 2019 with a substance-related ICD-10 diagnosis. We calculated the proportion of all ICU admissions with diagnoses related to any substance, and separately for alcohol, opioids, and stimulants and compared these across U.S. Census divisions and between urban and rural ICUs. Results: Out of 4,740,799 ICU admissions, 760,153 (16.0%) included at least one substance-related diagnosis. The highest burden of substance-related diagnoses was observed in the New England, Pacific, and Mountain divisions, where alcohol and opioid-related ICU admissions were most prevalent. Stimulant-related ICU admissions were disproportionately higher in the Pacific division. Urban ICUs generally reported a higher proportion of substance-related admissions compared to rural ICUs, with certain regional exceptions. Conclusion: There are substantial geographic and urban-rural differences in substance-related ICU admissions across the United States. Our findings suggest a need for region-specific strategies to address distinct substance use patterns and reduce the burden on critical care resources.